ConductScience.org, home

Paper25758928

Substitution treatment and HCV/HIV-infection in a sample of 31 German prisons for sentenced inmates.

Schulte B and 5 others. Int J Prison Health, 2009. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Substitution treatment and HCV/HIV-infection in a sample of 31 German prisons for sentenced inmates. Papers, record 25758928. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25758928

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Substitution treatment and HCV/HIV-infection in a sample of 31 German prisons for sentenced inmates.
PubMed
Journal
Int J Prison Health
PubMed
Year
2009
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.7
iCite
Revised in PubMed
2015-03-12
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schulte BB
2Stöver HH
3Thane KK
4Schreiter CC
5Gansefort DD
6Reimer JJ

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
HIV InfectionsMajor topic
Hepatitis CMajor topic
Opiate Substitution TreatmentMajor topic
PrisonsMajor topic
Substance Abuse, IntravenousMajor topic
Cross-Sectional Studies
Germany
Humans
Prevalence
Prisoners
Risk Factors

Source PubMed

Download CSV of topics

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
37055763HIV and HCV among drug users and people living in prisons in Germany 2022: WHO elimination targets as reflected in practice.Harm Reduct J2023https://conductscience.org/library/papers/37055763PubMed
36986354Challenges Facing Viral Hepatitis C Elimination in Lebanon.Pathogens2023https://conductscience.org/library/papers/36986354PubMed
36736343[Strategietreffen: Virushepatitis in Deutschland eliminieren].Z Gastroenterol2023https://conductscience.org/library/papers/36736343PubMed
34823636HIV seroprevalence in five key populations in Europe: a systematic literature review, 2009 to 2019.Euro Surveill2021https://conductscience.org/library/papers/34823636PubMed
34136654Hepatitis C virus: Current steps toward elimination in Germany and barriers to reaching the 2030 goal.Health Sci Rep2021https://conductscience.org/library/papers/34136654PubMed
33014960Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping Review.Front Public Health2020https://conductscience.org/library/papers/33014960PubMed
32903474Prevalence of Opioid Dependence and Opioid Agonist Treatment in the Berlin Custodial Setting: A Cross-Sectional Study.Front Psychiatry2020https://conductscience.org/library/papers/32903474PubMed
32446130A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System.Int J Drug Policy2020https://conductscience.org/library/papers/32446130PubMed
32156295Implementation of opioid maintenance treatment in prisons in North Rhine-Westphalia, Germany - a top down approach.Subst Abuse Treat Prev Policy2020https://conductscience.org/library/papers/32156295PubMed
32150561The epidemiology of Hepatitis B, C and D in Germany: A scoping review.PLoS One2020https://conductscience.org/library/papers/32150561PubMed
30642429Medicine in the Penal System.Dtsch Arztebl Int2018https://conductscience.org/library/papers/30642429PubMed
30621658Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe.BMC Public Health2019https://conductscience.org/library/papers/30621658PubMed
29065873High variability of TB, HIV, hepatitis C treatment and opioid substitution therapy among prisoners in Germany.BMC Public Health2017https://conductscience.org/library/papers/29065873PubMed
27595567
High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
BMC Public Health2016https://conductscience.org/library/papers/27595567PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25758928

GET https://conductscience.org/api/papers/v1/25758928/authors